euromuscular electrical stimulation to enhance the exercise benefits for muscle functions during spaceflight
- Conditions
- M62.5Muscle wasting and atrophy, not elsewhere classified
- Registration Number
- DRKS00032106
- Lead Sponsor
- niversität Trieste
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 16
Astronauts from ESA, NASA, the Japanese or Canadian space agencies flying to the ISS.
- Subjects with ferromagnetic metal implants, pacemakers or electronic materials cannot be included in the study due to the MRI scan
- Previous head surgery with metal implants
- Claustrophobia
- Previous knee surgery or ligament injuries
- Personal or family history of epilepsy, uncontrolled high blood pressure, bleeding tendency, use of aspirin or warfarin, impaired blood clotting, history of nerve, muscular or skeletal disorders of the leg
- Allergies to kinesiology tape, stickers, electrode gel or Aquasonic ultrasound gel
- Cardiac diseases
- Pregnant women
- MRI cannot be performed on persons with:
Implanted pacemakers
Intracranial aneurysm clips
Cochlear implants
Certain prosthetic devices
Implanted drug infusion pumps
Neurostimulators
Bone growth stimulators
Certain intrauterine contraceptive devices (e.g. with iron-based metal)
All other types of iron-based metal implants.
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Measurements before and immediately after spaceflight of: <br>- Muscle neuromuscular functions (muscle strength, fatigue resistance, voluntary activation capacity, motor unit function), muscle volume and architecture (MRI) <br>- Muscle perfusion (SO2, blood flow, Hb content) measured with NIRS and O2C <br>- Maximum oxygen uptake (V'O2) and maximum CO2 release (V'CO2) <br>- Blood analyses: circulating myokines, microRNAs, inflammatory and angiogenesis biomarkers, parameters of neuromuscular interaction, muscle physiology, etc. <br>- Questionnaires (muscular symptoms, previous diseases etc.)
- Secondary Outcome Measures
Name Time Method Comparison of the degree of muscular degradation due to the stay in weightlessness between the intervention and control groups